259 related articles for article (PubMed ID: 34448823)
41. More than a masquerade syndrome: atypical presentations of vitreoretinal lymphomas.
AlQahtani A; Touitou V; Cassoux N; Aknin C; Merle-Beral H; Bodaghi B; LeHoang P
Ocul Immunol Inflamm; 2014 Jun; 22(3):189-96. PubMed ID: 24475870
[TBL] [Abstract][Full Text] [Related]
42. A comprehensive overview of diagnosis, imaging and treatment of vitreoretinal lymphoma.
Menean M; Giuffrè C; Cicinelli MV; Marchese A; Modorati G; Bandello F; Miserocchi E
Eur J Ophthalmol; 2023 Nov; ():11206721231211931. PubMed ID: 37956540
[TBL] [Abstract][Full Text] [Related]
43. Vitreoretinal lymphoma: Central nervous system lymphoma risk with unilateral or bilateral ocular tumour. A multicentre collaboration.
Dalvin LA; Pulido JS; Shields CL; Marchese A; Miserocchi E; Frenkel S; Pe'er J
Eye (Lond); 2023 Jan; 37(1):54-61. PubMed ID: 34999721
[TBL] [Abstract][Full Text] [Related]
44. Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma.
Gu J; Jiang T; Liu S; Ping B; Li R; Chen W; Wang L; Huang X; Xu G; Chang Q
Front Oncol; 2022; 12():932674. PubMed ID: 35928872
[TBL] [Abstract][Full Text] [Related]
45. Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcomes.
Levasseur SD; Wittenberg LA; White VA
JAMA Ophthalmol; 2013 Jan; 131(1):50-5. PubMed ID: 23307208
[TBL] [Abstract][Full Text] [Related]
46. CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential.
Yonese I; Takase H; Yoshimori M; Onozawa E; Tsuzura A; Miki T; Mochizuki M; Miura O; Arai A
Eur J Haematol; 2019 Feb; 102(2):191-196. PubMed ID: 30390359
[TBL] [Abstract][Full Text] [Related]
47. Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas.
Braggio E; Van Wier S; Ojha J; McPhail E; Asmann YW; Egan J; da Silva JA; Schiff D; Lopes MB; Decker PA; Valdez R; Tibes R; Eckloff B; Witzig TE; Stewart AK; Fonseca R; O'Neill BP
Clin Cancer Res; 2015 Sep; 21(17):3986-94. PubMed ID: 25991819
[TBL] [Abstract][Full Text] [Related]
48. A Case of Spontaneous Regression and Recurrence of Primary Vitreoretinal Lymphoma.
Kim Y; Shin S; Lee ST; Lee CS
Ocul Immunol Inflamm; 2022; 30(7-8):1980-1983. PubMed ID: 34255584
[TBL] [Abstract][Full Text] [Related]
49. Vitreoretinal lymphoma: a diagnostic challenge.
Sáenz Decker E; García Fernández M; Gómez De la Torre R; Coto Hernández R; Santana García LI
Arch Soc Esp Oftalmol (Engl Ed); 2023 Dec; 98(12):718-722. PubMed ID: 37813184
[TBL] [Abstract][Full Text] [Related]
50. Aurora borealis and string of pearls in vitreoretinal lymphoma: patterns of vitreous haze.
Marchese A; Miserocchi E; Giuffrè C; Cicinelli MV; Querques G; Bandello F; Modorati G
Br J Ophthalmol; 2019 Nov; 103(11):1656-1659. PubMed ID: 30709808
[TBL] [Abstract][Full Text] [Related]
51. Vitreoretinal Lymphoma: A Literature Review and Introduction of a New Diagnostic Method.
Takhar J; Doan T; Gonzales JA
Asia Pac J Ophthalmol (Phila); 2021 Jan; 10(1):93-98. PubMed ID: 33481398
[TBL] [Abstract][Full Text] [Related]
52. MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.
Takeuchi T; Yamaguchi M; Kobayashi K; Miyazaki K; Tawara I; Imai H; Ono R; Nosaka T; Tanaka K; Katayama N
Cancer; 2017 Apr; 123(7):1166-1173. PubMed ID: 27915469
[TBL] [Abstract][Full Text] [Related]
53. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes.
Akpek EK; Ahmed I; Hochberg FH; Soheilian M; Dryja TP; Jakobiec FA; Foster CS
Ophthalmology; 1999 Sep; 106(9):1805-10. PubMed ID: 10485554
[TBL] [Abstract][Full Text] [Related]
54. Vitreous proteomics, a gateway to improved understanding and stratification of diverse uveitis aetiologies.
Schrijver B; Kolijn PM; Ten Berge JCEM; Nagtzaam NMA; van Rijswijk ALCT; Swagemakers SMA; van der Spek PJ; Missotten TOAR; van Velthoven MEJ; de Hoog J; van Hagen PM; Langerak AW; Dik WA
Acta Ophthalmol; 2022 Jun; 100(4):403-413. PubMed ID: 34318583
[TBL] [Abstract][Full Text] [Related]
55. Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas.
Elbert M; Neumann F; Kiefer M; Christofyllakis K; Balensiefer B; Kos I; Carbon G; Kaddu-Mulindwa D; Bittenbring JT; Fadle N; Regitz E; Fend F; Bonzheim I; Thurner L; Bewarder M
Sci Rep; 2024 Apr; 14(1):9571. PubMed ID: 38671086
[TBL] [Abstract][Full Text] [Related]
56. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.
Castellino A; Pulido JS; Johnston PB; Ristow KM; Nora Bennani N; Inwards DJ; Macon WR; Micallef INM; King RL; Salomao DR; Witzig TE; Habermann TM; Nowakowski GS
Am J Hematol; 2019 Mar; 94(3):291-298. PubMed ID: 30516868
[TBL] [Abstract][Full Text] [Related]
57. Relationship between vitreoretinal lymphoma and the site of lymphoma development in the central nervous system.
Maruyama K; Iwahashi C; Hashida N; Ohguro N; Nishida K
Jpn J Ophthalmol; 2022 Mar; 66(2):142-150. PubMed ID: 34860298
[TBL] [Abstract][Full Text] [Related]
58. Diagnostic value of genetic mutation analysis and mutation profiling of cell-free DNA in intraocular fluid for vitreoretinal lymphoma.
Chen X; Hu Y; Su W; Yang S; Wang X; Zhang P; Hong X; Liang C; Qian Z; Li Z; Tao Y; Huang H; Liang D
Cancer Commun (Lond); 2022 Nov; 42(11):1217-1221. PubMed ID: 35920016
[No Abstract] [Full Text] [Related]
59. More Accurate Diagnosis of Vitreoretinal Lymphoma Using a Combination of Diagnostic Test Results: A Prospective Observational Study.
Tanaka R; Kaburaki T; Taoka K; Karakawa A; Tsuji H; Nishikawa M; Yatomi Y; Shinozaki-Ushiku A; Ushiku T; Araki F
Ocul Immunol Inflamm; 2022 Aug; 30(6):1354-1360. PubMed ID: 33793360
[TBL] [Abstract][Full Text] [Related]
60. Vitreous levels of interleukin-35 as a prognostic factor in B-cell vitreoretinal lymphoma.
Takeda A; Hasegawa E; Nakao S; Ishikawa K; Murakami Y; Hisatomi T; Arima M; Yawata N; Oda Y; Kimura K; Yoshikawa H; Sonoda KH
Sci Rep; 2020 Sep; 10(1):15715. PubMed ID: 32973297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
